Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1429-1440
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Characteristic | Before PSM | After PSM | ||||
Resolved HBV, n = 11186 | Healthy controls, n = 5666 | P value | Resolved HBV, n = 5015 | Healthy controls, n = 5015 | P value | |
Age, year | 57.41 ± 9.31 | 51.29 ± 11.25 | < 0.001 | 53.39 ± 10.23 | 53.32 ± 10.32 | 0.729 |
Male | 3445 (30.80) | 1553 (27.41) | < 0.001 | 1252 (24.97) | 1331 (26.54) | 0.071 |
BMI, kg/m2 | 24.20 ± 3.60 | 24.13 ± 3.88 | 0.266 | 24.12 ± 3.83 | 24.16 ± 3.82 | 0.619 |
Body fat % | 29.41 ± 7.46 | 29.52 ± 7.44 | 0.375 | 29.87 ± 7.45 | 29.71 ± 7.42 | 0.309 |
WC, cm | 83.48 ± 9.78 | 82.82 ± 10.32 | < 0.001 | 82.66 ± 10.10 | 83.02 ± 10.15 | 0.076 |
Metabolic parameters | ||||||
MASLD | 4670 (41.75) | 2229 (39.34) | 0.003 | 2007 (40.02) | 2033 (40.54) | 0.597 |
Diabetes | 1383 (12.36) | 474 (8.37) | < 0.001 | 503 (10.03) | 463 (9.23) | 0.176 |
Hypertension | 2072 (18.52) | 724 (12.78) | < 0.001 | 731 (14.58) | 711 (14.18) | 0.569 |
Hyperlipidemia | 1431 (12.79) | 548 (9.67) | < 0.001 | 499 (9.95) | 539 (10.75) | 0.190 |
Glucose, mg/dL | 98 (21.71) | 95 (19.00) | < 0.001 | 97 (21.48) | 96 (19.25) | 0.166 |
HbA1c, % | 5.93 ± 0.84 | 5.80 ± 0.75 | < 0.001 | 5.86 ± 0.84 | 5.83 ± 0.77 | 0.106 |
TG, mg/dL | 120.91 ± 99.13 | 115.42 ± 77.93 | < 0.001 | 118.04 ± 116.37 | 117.85 ± 78.99 | 0.924 |
CHO, mg/dL | 199.78 ± 36.71 | 197.94 ± 36.28 | 0.002 | 198.72 ± 36.05 | 199.22 ± 36.07 | 0.482 |
HDL, mg/dL | 55.26 ± 13.62 | 55.89 ± 13.74 | 0.005 | 55.80 ± 13.57 | 55.96 ± 13.74 | 0.568 |
LDL, mg/dL | 122.75 ± 32.30 | 121.78 ± 32.15 | 0.065 | 122.19 ± 31.92 | 122.44 ± 31.91 | 0.695 |
Liver parameters | ||||||
AST, U/L | 25.11 ± 11.28 | 24.35 ± 12.12 | < 0.001 | 24.31 ± 12.71 | 24.56 ± 12.29 | 0.325 |
ALT, U/L | 23.05 ± 20.82 | 23.10 ± 22.66 | 0.885 | 22.48 ± 24.76 | 23.24 ± 23.11 | 0.113 |
GGT, U/L | 22.74 ± 25.62 | 22.21 ± 20.17 | 0.138 | 21.79 ± 25.47 | 22.47 ± 20.53 | 0.143 |
Fatty liver index | 25.73 ± 23.03 | 24.85 ± 24.05 | 0.023 | 24.48 ± 23.63 | 25.25 ± 23.87 | 0.103 |
FIB-4 | 1.46 ± 0.74 | 1.23 ± 0.61 | < 0.001 | 1.30 ± 0.61 | 1.30 ± 0.62 | 0.550 |
FIB-4 > 2 | 1739 (15.55) | 578(10.20) | < 0.0001 | 558 (11.13) | 576 (11.49) | 0.5703 |
Other parameters | ||||||
Carotid plaque | 3684 (32.93) | 1266 (22.34) | < 0.001 | 1253 (24.99) | 1250 (24.93) | 0.945 |
- Citation: Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, Kao JH. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol 2024; 16(12): 1429-1440
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1429.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1429